Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.81 -0.05 (-0.62%)
As of: Oct 23, 2026 · 3:58 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Change in Accured Expenses (2022 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Change in Accured Expenses of $272,474 in Q2 2026, compared with -$95,816 a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Change in Accured Expenses (2022 - 2026) Analysis & Trends

On a TTM basis, Aspire Biopharma Holdings' Change in Accured Expenses came in at $1.02 million as of Jun 30, 2026, up 144.3% year-over-year; for FY2025, it came in at $1.05 million, up 19.2% from FY2024.

  • Annual Change in Accured Expenses has a four-year compound annual growth rate of 687.0% (FY2021 to FY2025).
  • Across earlier years, Change in Accured Expenses came in at $878,610 in FY2024, -$28,629 in FY2023, $125,533 in FY2022 and $273.00 in FY2021.
  • Quarterly Change in Accured Expenses has ranged from -$316,955 in Q1 2026 to $781,667 in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$316,955 (Q1 2026), $781,667 (Q4 2025) and $280,780 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 272,474.00
Mar 31, 2026 -316,955.00
Dec 31, 2025 781,667.00
Sep 30, 2025 280,780.00
Jun 30, 2025 -95,816.00
Mar 31, 2025 80,457.00
Jun 30, 2024 219,067.00
Mar 31, 2024 213,005.00
Dec 31, 2023 47,626.00
Sep 30, 2023 2,712.00
Jun 30, 2023 -102,065.00
Mar 31, 2023 23,098.00
Dec 31, 2022 84,618.00
Sep 30, 2022 12,239.00
Jun 30, 2022 64,709.00
Mar 31, 2022 -36,033.00
API Access

Aspire Biopharma Holdings, Inc. Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ASBP&period=max&api_key=YOUR_API_KEY